BioMarin Pharmaceuticals BMRN Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.07B+193% | $1.31B+39.1% | $1.25B+85.1% | $1.21B+24.9% | $1.05B+40.4% | ||
| $0-100% | $248.93M+27.7% | $227.73M-10.7% | $218.31M-13.4% | $223.53M-25.4% | ||
| $903.91M+22.3% | $908.21M+37.5% | $790.27M+1.6% | $855.86M+23.8% | $739.18M+16.0% | ||
| $1.27B-0.1% | $1.3B+5.4% | $1.38B+17.2% | $1.34B+13.2% | $1.27B+12.0% | ||
| $4.61B+32.8% | $3.95B+22.3% | $3.85B+26.1% | $3.81B+16.7% | $3.47B+16.2% | ||
| $958.07M-7.2% | $952.51M-8.7% | $1.04B-0.7% | $1.03B-2.1% | $1.03B-2.6% | ||
| $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | ||
| $204.66M-17.3% | $213.84M-16.2% | $233.11M-10.7% | $239.62M-9.8% | $247.35M-11.6% | ||
| $8.59B+20.2% | $7.59B+8.7% | $7.61B+11.1% | $7.46B+5.5% | $7.15B+4.0% | ||
| $793.15M+26.3% | $759.03M+25.0% | $798.44M+11.6% | $684.25M+19.5% | $628.21M+5.8% | ||
| $793.15M+26.3% | $759.03M+25.0% | $798.44M+11.6% | $684.25M-35.9% | $628.21M-42.3% | ||
| $1.43B+138% | $597.18M— | $600M0.0% | $600M-45.5% | $600M-45.5% | ||
| $2.38B+75.8% | $1.51B+13.2% | $1.56B+8.4% | $1.43B-19.7% | $1.35B-24.8% | ||
| 500M0.0% | 500M+261,680% | 500M0.0% | 500M0.0% | 500M0.0% | ||
| $259.73M+2,983% | $154.21M+179% | $200.78M+163% | $231.52M+154% | -$9.01M+98.3% | ||
| $6.21B+7.2% | $6.09B+7.6% | $6.06B+11.9% | $6.03B+14.0% | $5.79B+14.2% | ||
| $8.59B+20.2% | $7.59B+8.7% | $7.61B+11.1% | $7.46B+5.5% | $7.15B+4.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioMarin Pharmaceuticals's total assets?
- BioMarin Pharmaceuticals (BMRN) holds $8.6B in total assets, up 20.2% year over year.
- How much debt does BioMarin Pharmaceuticals have?
- BioMarin Pharmaceuticals carries $1.4B in total debt against $6.2B of shareholders' equity, a debt-to-equity ratio of 0.23.
- How much cash does BioMarin Pharmaceuticals have?
- BioMarin Pharmaceuticals holds $3.1B in cash and equivalents.
- Can BioMarin Pharmaceuticals cover its short-term obligations?
- Its current ratio is 5.81 — current assets exceed current liabilities.
- Where does BioMarin Pharmaceuticals's balance sheet data come from?
- Every line is extracted from BioMarin Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
